Gliknik is expert in immune modulation. We have several research platforms, each of which holds the promise of producing multiple innovative products:
The Immunomodulator Platform. Peptide drugs that generate immune responses against targeted cancer epitopes with the goal of turning a cancer patient's immune system against his or her tumor.
The StradomerTM Platform. Recombinant drugs for a wide range of inflammatory and autoimmune diseases.
The StradobodyTM Platform. Biosimilars more potent than the underlying monoclonal antibodies at killing tumor cells.